These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12389591)

  • 21. Oxaliplatin shows significant benefit over standard therapy in early-stage colon cancer.
    Oncology (Williston Park); 2004 Sep; 18(10):1313. PubMed ID: 15526833
    [No Abstract]   [Full Text] [Related]  

  • 22. Carboplatin.
    Cancer Invest; 1989; 7(1):107. PubMed ID: 2660953
    [No Abstract]   [Full Text] [Related]  

  • 23. A historical perspective on oxaliplatin: rethinking the role of platinum compounds and learning from near misses.
    Cvitkovic E
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):1-3. PubMed ID: 9609102
    [No Abstract]   [Full Text] [Related]  

  • 24. [Platinum complexes in cancer pharmacy. Individual patient cytostatic preparation].
    Warnke U
    Pharm Unserer Zeit; 2006; 35(2):110-6. PubMed ID: 16583564
    [No Abstract]   [Full Text] [Related]  

  • 25. Oxaliplatin in the adjuvant treatment of colon cancer.
    Barton MK
    CA Cancer J Clin; 2012; 62(1):3-4. PubMed ID: 22095255
    [No Abstract]   [Full Text] [Related]  

  • 26. [Oxaliplatin (Eloxatin). Progress in tumor therapy. 2004. Introduction].
    Schmoll HJ
    Onkologie; 2004 Aug; 27 Suppl 1():1. PubMed ID: 23570153
    [No Abstract]   [Full Text] [Related]  

  • 27. Whither carboplatin? A replacement for or an alternative to cisplatin?
    Gil A
    J Clin Oncol; 1987 Dec; 5(12):2041-2. PubMed ID: 3316520
    [No Abstract]   [Full Text] [Related]  

  • 28. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
    Berg D
    Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin.
    Elias D; Pocard M; Sideris L; Edè C; Ducreux M; Boige V; Lasser P
    Br J Surg; 2004 Apr; 91(4):455-6. PubMed ID: 15048746
    [No Abstract]   [Full Text] [Related]  

  • 30. [January 2004: a month of success with oxaliplatin and hope for patients with colorectal cancer].
    Tumori; 2004; 90(1):suppl 28-30. PubMed ID: 15143997
    [No Abstract]   [Full Text] [Related]  

  • 31. Possible impact of the NHK special questioning cancer treatment in Japan on clinicians' prescriptions of oxaliplatin.
    Matsumura T; Yuji K; Nakamura T; Beppu F; Kusumi E; Hamaki T; Kobayashi K; Kishi Y; Onishi M; Kodama Y; Tanaka Y; Kami M
    Jpn J Clin Oncol; 2008 Jan; 38(1):78-83. PubMed ID: 18258716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oxaliplatin].
    Bascioni R
    Suppl Tumori; 2004; 3(4):S111-2. PubMed ID: 15206232
    [No Abstract]   [Full Text] [Related]  

  • 34. Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinoma.
    Briasoulis E; Rontogianni D; Karavasilis V; Pavlidis N
    Thyroid; 2005 Jun; 15(6):614-7. PubMed ID: 16029130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraplatin (carboplatin). Current status and future prospects. Proceedings of a satellite symposium held at Stockholm, Sweden, 19th June 1985, during the 3rd European Conference on Clinical Oncology.
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():1-152. PubMed ID: 3910214
    [No Abstract]   [Full Text] [Related]  

  • 36. Experiences with the use of oxaliplatin in esophageal carcinoma.
    Albertsson M; Kadar L; Bergenfeldt M
    Acta Oncol; 2006; 45(1):103-5. PubMed ID: 16464806
    [No Abstract]   [Full Text] [Related]  

  • 37. [Platinum complexes as potential antineoplastic drugs].
    Kuduk-Jaworska J
    Postepy Hig Med Dosw; 1984; 38(3):281-322. PubMed ID: 6398870
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic sinusoidal obstruction syndrome reduces the effect of oxaliplatin in colorectal liver metastases.
    Robinson SM; White SA
    Histopathology; 2012 Dec; 61(6):1247-8. PubMed ID: 23043422
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic variants as potential predictive biomarkers in advanced colorectal cancer patients treated with oxaliplatin-based chemotherapy.
    Bahrami A; Amerizadeh F; Hassanian SM; ShahidSales S; Khazaei M; Maftouh M; Ghayour-Mobarhan M; Ferns GA; Avan A
    J Cell Physiol; 2018 Mar; 233(3):2193-2201. PubMed ID: 28422287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxaliplatin: a review of approved uses.
    Stein A; Arnold D
    Expert Opin Pharmacother; 2012 Jan; 13(1):125-37. PubMed ID: 22149372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.